What is Xarelto?

Xarelto is a prescription medication used to prevent blood clots from forming as the result of an irregular heartbeat/atrial fibrillation. Also called Rivaroxaban, the drug is commonly given after hip or knee replacement surgery. Patients with other types of blood clots including deep vein thrombosis (DVT) or pulmonary embolus (PE) may be given Xarelto along with those who need to prevent past blood clots from forming again. The drug is considered an anticoagulant and works by blocking specific clotting proteins in the patient’s blood.

Xarelto Side Effects

One of the most common side effects of the drug is unusual bleeding, including random nosebleeds or excessive bleeding from cuts. While this is normal in small doses, severe instances of excessive bleeding can signify a more dangerous reaction to Xarelto.

Patients who take Xarelto may also suffer one or more of the following side effects:

  • Dizziness
  • Headaches
  • Muscle pain
  • Vomiting
  • Edema – an abnormal swelling of fluid in the tissues which can cause severe pain

Severe Xarelto Side Effects

The most severe side effect from taking Xarelto is uncontrolled bleeding. This is especially dangerous if the bleeding happens near a major organ, such as the kidneys, lungs, or brain. Loss or interruption of blood flow to these organs can cause them to lose some or all of their functionality. Uncontrolled bleeding can also result in pools of blood forming within the body which can lead to other severe health risks. Because Xarelto’s purpose is to prevent clotting, these bleeding events continue until the drug is flushed out of the system but will persist if the patient keeps taking the drug.

Complications from Xarelto

The most severe and deadly complications from taking Xarelto include:

  • Hemorrhage
  • Abnormal organ function
  • Collection of clotted blood in an organ
  • Permanent damage to heart, lungs, and other organs
  • Internal bleeding
  • Death

Xarelto Lawsuit

Lawsuits against Xarelto have been consolidated in federal court and number over 7,200 at the end September 2016. Patients have filed for damages caused by serious health complications after taking Xarelto and accuse the drug of posing a significant risk of uncontrollable bleeding episodes. This fact was allegedly omitted by manufacturers Bayer AG and Janssen Pharmaceuticals, that are a subdivision of Johnson & Johnson, and the public was not properly aware of it.

The first Xarelto bellwether trials are scheduled for early 2017. This leaves a limited amount of time for other plaintiffs to file suit should future cases be barred by the Statute Of Limitations.